Bayer’s ruthless bid for immunity SILENCES cancer victims and overrides the rule of law

In the heartland of America, a sinister corporate power play is unfolding—one that threatens to strip citizens of their constitutional rights while shielding a pharmaceutical giant from accountability for its deadly product. Bayer, the agrochemical behemoth that inherited Monsanto’s toxic legacy, is waging a multi-state lobbying war to secure legal immunity for Roundup, its glyphosate-based herbicide linked to non-Hodgkin’s lymphoma. With billions in jury verdicts and settlements piling up, Bayer isn’t reforming its product or warning consumers—it’s rewriting the law.

This isn’t just about pesticides. It’s about corporate tyranny, the erosion of state sovereignty, and the betrayal of farmers, landscapers, and consumers who trusted a product they believed was safe. Bayer’s playbook mirrors Big Pharma’s vaccine industry tactics: lobby lawmakers, bypass courts, and silence victims. But the backlash is growing, exposing a company desperate to evade justice—no matter the cost to public health.

Key points:

• Bayer is pushing state-level legislation to block lawsuits alleging Roundup causes cancer, effectively stripping victims of their right to a jury trial.
• Missouri courts have already ruled against Bayer, awarding billions in damages, but the company is now lobbying to override state laws with federal preemption.
• The EPA’s outdated pesticide regulations leave a gaping loophole, allowing Bayer to exploit weak enforcement while avoiding accountability.
• Farmers, health advocates, and bipartisan lawmakers are fighting back, exposing Bayer’s dark money tactics and corporate manipulation.
• The outcome of this battle will determine whether corporations can poison citizens with impunity—or if justice will prevail.

Bayer’s legal Hail Mary: Rewriting the rules to dodge accountability

Bayer’s desperation is palpable. After acquiring Monsanto in 2018, the company inherited not just Roundup but a legal nightmare—over 54,000 lawsuits linking glyphosate to cancer. With jury verdicts totaling nearly $20 billion, Bayer’s response hasn’t been to reformulate its product or add cancer warnings. Instead, it’s deploying an army of lobbyists to convince state legislatures that EPA approval should shield it from all liability.

Missouri, home to Bayer’s North American Crop Science headquarters, became ground zero for this fight. The company flooded the state with lobbyists, pushing Senate Bill 14 and House Bill 2763—both designed to block “failure-to-warn” claims. But Bayer underestimated the backlash.

“Monsanto is trying to push legislation that would take away constitutional rights,” says Missouri trial lawyer Matt Clement, who has successfully represented Roundup victims. “It has not been successful in getting courts to buy its preemption argument, so it is resorting to trying to pass state legislation that will do what most courts have refused to do.”

The EPA loophole: How Bayer exploits weak enforcement

The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), last updated in 1972, was meant to ensure pesticide safety. But it has a fatal flaw: private citizens can’t sue under FIFRA—only the EPA can enforce it. And with the agency reviewing chemicals only every 15 years, there’s no real accountability.

“State law claims are the only way for private citizens to hold companies accountable,” Clement explains. “If the proposed legislation takes that away, there is nothing left for an injured person to do.”

Bayer knows this. Instead of fixing Roundup, it’s exploiting regulatory gaps, pouring millions into lobbying groups like the Modern Ag Alliance and the Protecting America Initiative. In Georgia, Bayer succeeded—SB 144 became law, threatening a $2.1 billion verdict for plaintiff John Barnes. But in Missouri, Bayer’s heavy-handed tactics backfired.

Related: No immunity for Monsanto: Oregon court overturns Monsanto/Bayer victory in ongoing Roundup trial.

Dark money and dirty tricks: Bayer’s PR war backfires

When nine Missouri Freedom Caucus senators resisted Bayer’s bill, the company retaliated with vicious direct-mail flyers accusing them of “betraying farmers” and aiding China. The senators, furious at what they called “dark money” attacks, launched an ethics investigation and filibustered the bill to death.

The backlash was bipartisan. Twenty-four House Republicans and 48 Democrats rejected the bill, signaling a rare moment of unity against corporate overreach. Bayer’s aggressive ads and sponsorship of Governor Mike Kehoe’s inauguration only fueled perceptions of corruption.

Bayer’s endgame is clear: secure federal preemption through the Farm Bill or the Supreme Court, nullifying state-level lawsuits. But Congress could just as easily amend FIFRA to protect victims’ rights. The Trump administration could also direct the EPA to update glyphosate’s labeling, closing Bayer’s escape hatch.

This battle isn’t just about Roundup—it’s about whether corporations can poison people without consequence. Farmers, consumers, and lawmakers must decide: Will we let Bayer rewrite the rules, or will we demand accountability?

Sources include:

Modernity.news

Zerohedge.com

NaturalNews.com